60 related articles for article (PubMed ID: 11739105)
1. Troglitazone inhibits glutamine metabolism in rat mesangial cells.
Routh R; McCarthy K; Welbourne T
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E231-8. PubMed ID: 11739105
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells.
Welbourne T; Su G; Coates G; Routh R; McCarthy K; Battarbee H
Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1600-7. PubMed ID: 12010740
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
Routh RE; Johnson JH; McCarthy KJ
Kidney Int; 2002 Apr; 61(4):1365-76. PubMed ID: 11918743
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
Welbourne T; Friday E; Fowler R; Turturro F; Nissim I
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F100-10. PubMed ID: 14506076
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells.
Tsuchiya T; Shimizu H; Shimomura K; Mori M
Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA
Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
[TBL] [Abstract][Full Text] [Related]
7. Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells.
Coates G; Nissim I; Battarbee H; Welbourne T
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E729-37. PubMed ID: 12217890
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells.
Asano T; Wakisaka M; Yoshinari M; Nakamura S; Doi Y; Fujishima M
Metabolism; 2000 Mar; 49(3):308-13. PubMed ID: 10726906
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone regulates anaplerosis via a pull/push affect on glutamate dehydrogenase mediated glutamate deamination in kidney-derived epithelial cells; implications for the Warburg effect.
Oliver R; Friday E; Turturro F; Welbourne T
Cell Physiol Biochem; 2010; 26(4-5):619-28. PubMed ID: 21063099
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
McCarthy KJ; Routh RE; Shaw W; Walsh K; Welbourne TC; Johnson JH
Kidney Int; 2000 Dec; 58(6):2341-50. PubMed ID: 11115068
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Ohta MY; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2000 Feb; 49(2):163-6. PubMed ID: 10690939
[TBL] [Abstract][Full Text] [Related]
12. The glutamine/glutamate couplet and cellular function.
Welbourne T; Routh R; Yudkoff M; Nissim I
News Physiol Sci; 2001 Aug; 16():157-60. PubMed ID: 11479364
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.
Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W
J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons.
Uryu S; Harada J; Hisamoto M; Oda T
Brain Res; 2002 Jan; 924(2):229-36. PubMed ID: 11750908
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA
J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
